Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Revenue (2016 - 2025)

Marimed (MRMD) has disclosed Revenue for 15 consecutive years, with $40.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Revenue changed 0.04% to $40.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $157.2 million, a 0.44% change, with the full-year FY2024 number at $158.0 million, up 6.3% from a year prior.
  • Revenue was $40.6 million for Q3 2025 at Marimed, up from $39.6 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $40.6 million in Q3 2025 to a low of $24.6 million in Q1 2021.
  • A 5-year average of $35.8 million and a median of $36.5 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: skyrocketed 238.9% in 2021, then fell 2.05% in 2025.
  • Marimed's Revenue stood at $31.0 million in 2021, then increased by 15.42% to $35.8 million in 2022, then increased by 8.57% to $38.9 million in 2023, then increased by 0.25% to $39.0 million in 2024, then grew by 4.13% to $40.6 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Revenue are $40.6 million (Q3 2025), $39.6 million (Q2 2025), and $38.0 million (Q1 2025).